GlassScriptPhysician profile
Jennifer A Steele
NPI 1992753123
$10,426.85
in general payments reported to CMS, 2019-2025
40 companies · $2,335 in 2025
The $2,335 reported for 2025 was more than what 79% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,433 · 2020: $560 · 2021: $976 · 2022: $1,330 · 2023: $1,624 · 2024: $2,170 · 2025: $2,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,882 · Education: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,882.07 |
| Education | $245.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $921.75 | 2019-2025 | |
| Janssen Biotech, INC. | $662.57 | 2019-2025 | Tremfya, Simponi Aria, Stelara |
| Abbvie INC. | $614.76 | 2019-2025 | Botox, Rinvoq, Skyrizi |
| Arcutis Biotherapeutics, INC. | $599.55 | 2023-2025 | Zoryve |
| Genzyme Corporation | $563.61 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $556.46 | 2019-2024 | Ilumya |
| Almirall LLC | $538.19 | 2019-2025 | Klisyri, Seysara |
| Amgen INC. | $458.15 | 2019-2025 | Otezla, Enbrel, Otezla |
| Regeneron Healthcare Solutions, INC. | $452.11 | 2019-2025 | Dupixent, Libtayo |
| Leo Pharma INC. | $449.42 | 2019-2025 | Adbry, Anzupgo |
| Novartis Pharmaceuticals Corporation | $437.60 | 2019-2025 | |
| Galderma Laboratories, L.P. | $424.25 | 2019-2025 | Nemluvio, Aklief |
| Mayne Pharma Commercial LLC | $377.06 | 2019-2025 | |
| Incyte Corporation | $365.88 | 2021-2025 | Opzelura |
| Boehringer Ingelheim Pharmaceuticals, INC. | $357.29 | 2022-2025 | Spevigo |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Steele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.